Join us as we discuss viral diagnostics and pharmacology with Dr. Nigel McCracken, Chief Operating Officer of Virax Biolabs. Dr. McCracken shares his expertise in drug development, focusing on oncology and infectious diseases, and discusses the company's pioneering work in detecting immune responses and diagnosing viral diseases. The conversation covers the impact of technology advancements in the past decade, the introduction of the Immune Select Profile in the Virax Immune T Cell Diagnostic Platform, and the evolving landscape of viral diagnostics post-COVID-19. Dr. McCracken also shares insights on maintaining high-quality standards in R&D and offers advice for aspiring professionals in the fields of drug development and diagnostics.https://www.viraxbiolabs.com/00:00 Introduction and Welcome00:40 Meet Dr. Nigel McCracken01:29 Nigel's Journey in Pharmacology05:08 Innovations at Virax Biolabs09:05 Impact of COVID-19 on Viral Diagnostics12:53 Ensuring Quality in Diagnostics16:37 Future Trends in Viral Diagnostics20:20 Advice for Aspiring Researchers23:13 Nigel's Personal Insights24:20 Conclusion and FarewellQualio website:https://www.qualio.com/ Previous episodes:https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez

Ver todos los episodios